Literature DB >> 11345808

Late effects in long-term survivors of ALL in childhood: experiences from the SPOG late effects study.

N von der Weid1.   

Abstract

With the use of more intensive regimens including prophylactic CNS treatment, the prognosis of children with ALL has dramatically improved over the last three decades. The aim of this cross-sectional, nationwide study was to comprehensively assess long-term toxicity in ALL survivors, with special attention given to neuropsychological morbidity, and to look for possible differences in cognitive outcome between children having received prophylactic cranial irradiation and those not having received it. Between 1994 and 1996, long-term survivors of ALL were assessed in a multi-center setting according to a standardized protocol which included, besides usual clinical and laboratory investigations, a comprehensive endocrine work-up. Additionally, children having received anthracyclines were checked for possible late cardio-toxicity with echocardiography and ECG. Intellectual performance was evaluated with standardized neuropsychological tests (age-adapted versions of the Wechsler test). One-hundred and fifty patients were eligible for the study. The median age at diagnosis was 5 years and at evaluation 16 years, for a median follow-up of 10 years. Thirty-five patients had cranial irradiation as part of the prophylactic CNS treatment. One-hundred and forty (93%) of the 150 eligible patients were completely evaluated in terms of global long-term toxicity: 117 (83%) long-term survivors had no (n = 61) or only minimal (n = 56) late toxicity; 19 (14%) suffered from moderate impairments; 4 (3%) showed severe somatic or neuropsychological sequelae. Intellectual performance could be assessed in 147 (98%) of the 150 eligible patients. The mean global, verbal and non-verbal IQs (103, 105 and 101 respectively) of the ALL survivors as a group were comparable with those found in the general population. The results of the comparison between children having and those not having received prophylactic cranial irradiation showed: 1) significantly higher scores in chemotherapy-only treated patients, both for the global and the verbal performances; 2) significantly poorer results in specific items of the Wechsler test (short-term verbal memory, arithmetics, concentration/speed of processing) in irradiated children. These findings which show the deleterious role of cranial irradiation correlate well with many other reports found in the literature. However, they could have been influenced by the significantly longer time interval observed between therapy and evaluation in our irradiated patients. Prospective studies are needed to further characterize the potential neuropsychological hazards of chemotherapy and their evolution over time.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11345808     DOI: 2001/13/smw-09671

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  15 in total

1.  Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic review.

Authors:  Yin Ting Cheung; Kevin R Krull
Journal:  Neurosci Biobehav Rev       Date:  2015-04-07       Impact factor: 8.989

2.  Declines Noted in Cognitive Processes and Association With Achievement Among Children With Leukemia.

Authors:  Kathleen C Insel; Marilyn J Hockenberry; Lynette L Harris; Kari M Koerner; Zhenqiang Lu; Kristin B Adkins; Olga A Taylor; Patricia M Gundy; Ida M Moore
Journal:  Oncol Nurs Forum       Date:  2017-07-01       Impact factor: 2.172

3.  Assessment of Late Effects in Childhood Cancer Survivors: A Cross Sectional Study.

Authors:  Venkata Naga Malleswari Muddana; Biswajit Dubashi; S Nirmala Devi; Smita Kayal; Prasanth Ganesan
Journal:  Indian J Pediatr       Date:  2020-11-04       Impact factor: 1.967

Review 4.  Minimising the long-term adverse effects of childhood leukaemia therapy.

Authors:  Claudia Langebrake; Dirk Reinhardt; Jörg Ritter
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

5.  Late effects in survivors of childhood acute lymphoblastic leukemia: a study from Thai Pediatric Oncology Group.

Authors:  Samart Pakakasama; Gavivann Veerakul; Darin Sosothikul; Su-on Chainansamit; Vichai Laosombat; Pattra Thanarattanakorn; Rachata Lumkul; Surapon Wiangnon; Somporn Wangruangsathit; Nattee Narkbunnam; Somjai Kanjanapongkul
Journal:  Int J Hematol       Date:  2010-05-20       Impact factor: 2.490

6.  Attentional ability among survivors of leukaemia treated without cranial irradiation.

Authors:  J Rodgers; R Marckus; P Kearns; K Windebank
Journal:  Arch Dis Child       Date:  2003-02       Impact factor: 3.791

7.  Voxel-based morphometry and diffusion-tensor MR imaging of the brain in long-term survivors of childhood leukemia.

Authors:  L Porto; C Preibisch; E Hattingen; M Bartels; T Lehrnbecher; R Dewitz; F Zanella; C Good; H Lanfermann; R DuMesnil; M Kieslich
Journal:  Eur Radiol       Date:  2008-05-20       Impact factor: 5.315

Review 8.  Adult life after surviving lymphoma in childhood.

Authors:  Nicolas X von der Weid
Journal:  Support Care Cancer       Date:  2008-01-15       Impact factor: 3.603

9.  Concentration, working speed and memory: cognitive problems in young childhood cancer survivors and their siblings.

Authors:  L Wengenroth; C S Rueegg; G Michel; M E Gianinazzi; S Essig; N X von der Weid; M Grotzer; Claudia E Kuehni
Journal:  Pediatr Blood Cancer       Date:  2015-02-02       Impact factor: 3.167

10.  Systemic cancer therapy: achievements and challenges that lie ahead.

Authors:  Michael O Palumbo; Petr Kavan; Wilson H Miller; Lawrence Panasci; Sarit Assouline; Nathalie Johnson; Victor Cohen; Francois Patenaude; Michael Pollak; R Thomas Jagoe; Gerald Batist
Journal:  Front Pharmacol       Date:  2013-05-07       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.